Home › RegulatoryNEOGENOMICS INC - 8-K FilingNeoGenomics reports Q2 revenue growth to $202M with NGS up 26% and raises full-year guidanceSEC EDGAR · July 28, 2026, 20:07 UTCTickers: $NEO Read the full article at SEC EDGAR